| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Second Department of Surgery, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466, Japan
Recent articles have reported that loss of imprinting (LOI) of the endogenous gene H19 was frequently found in lung cancer and choriocarcinoma, common adulthood cancers. Consequently, we examined the status of genomic imprinting of H19 in 29 esophageal and 48 colorectal cancer specimens, and studied its relation to the expression of H19. Of 12 esophageal cancer specimens heterozygous for the RsaI polymorphism, 6 (50%) exhibited LOI of H19, but none of the 18 colorectal cancer specimens heterozygous for the RsaI polymorphism exhibited LOI of H19. The present study suggests that LOI of H19 may play an important role in the pathogenesis of esophageal cancer. Moreover, H19 expression was frequently abundant in both cancers, and all six esophageal cancers carried LOI with overexpressed H19. Therefore, this overexpression of H19 seems to be an important phenomenon for the development of esophageal and colorectal cancer cells.
1 This work was supported in part by the Ministry of Education, Science, and Culture, Japan.
2 To whom requests for reprints should be addressed.
Received 11/ 9/95. Accepted 12/13/95.
This article has been cited by other articles:
|
|
 |
|
  K. SAKURABA, T. YASUDA, M. SAKATA, Y.-H. KITAMURA, A. SHIRAHATA, T. GOTO, H. MIZUKAMI, M. SAITO, K. ISHIBASHI, G. KIGAWA, et al. Down-regulation of Tip60 Gene as a Potential Marker for the Malignancy of Colorectal Cancer Anticancer Res, October 1, 2009; 29(10): 3953 - 3955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. HIBI, T. GOTO, H. MIZUKAMI, Y.-H. KITAMURA, K. SAKURABA, M. SAKATA, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, et al. Demethylation of the CDH3 Gene Is Frequently Detected in Advanced Colorectal Cancer Anticancer Res, June 1, 2009; 29(6): 2215 - 2217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. HIBI, M. SAKATA, Y.-H. KITAMURA, K. SAKURABA, A. SHIRAHATA, T. GOTO, H. MIZUKAMI, M. SAITO, K. ISHIBASHI, G. KIGAWA, et al. Demethylation of the CD133 Gene Is Frequently Detected in Advanced Colorectal Cancer Anticancer Res, June 1, 2009; 29(6): 2235 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. HIBI, H. MIZUKAMI, A. SHIRAHATA, T. GOTO, M. SAKATA, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, and Y. SANADA Aberrant Methylation of the UNC5C Gene is Frequently Detected in Advanced Colorectal Cancer Anticancer Res, January 1, 2009; 29(1): 271 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. GOTO, H. MIZUKAMI, A. SHIRAHATA, M. SAKATA, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, Y. SANADA, and K. HIBI Aberrant Methylation of the p16 Gene Is Frequently Detected in Advanced Colorectal Cancer Anticancer Res, January 1, 2009; 29(1): 275 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. SHIRAHATA, M. SAKATA, K. SAKURABA, T. GOTO, H. MIZUKAMI, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, Y. SANADA, et al. Vimentin Methylation as a Marker for Advanced Colorectal Carcinoma Anticancer Res, January 1, 2009; 29(1): 279 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barsyte-Lovejoy, S. K. Lau, P. C. Boutros, F. Khosravi, I. Jurisica, I. L. Andrulis, M. S. Tsao, and L. Z. Penn The c-Myc Oncogene Directly Induces the H19 Noncoding RNA by Allele-Specific Binding to Potentiate Tumorigenesis. Cancer Res., May 15, 2006; 66(10): 5330 - 5337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Fellig, I Ariel, P Ohana, P Schachter, I Sinelnikov, T Birman, S Ayesh, T Schneider, N de Groot, A Czerniak, et al. H19 expression in hepatic metastases from a range of human carcinomas J. Clin. Pathol., October 1, 2005; 58(10): 1064 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Berteaux, S. Lottin, D. Monte, S. Pinte, B. Quatannens, J. Coll, H. Hondermarck, J.-J. Curgy, T. Dugimont, and E. Adriaenssens H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1 J. Biol. Chem., August 19, 2005; 280(33): 29625 - 29636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Berteaux, S Lottin, E Adriaenssens, F Van Coppenolle, X Leroy, J Coll, T Dugimont, and J-J Curgy Hormonal regulation of H19 gene expression in prostate epithelial cells J. Endocrinol., October 1, 2004; 183(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sakakibara, K. Hibi, Y. Kodera, K. Ito, S. Akiyama, and A. Nakao Plasminogen Activator Inhibitor-1 as a Potential Marker for the Malignancy of Esophageal Squamous Cell Carcinoma Clin. Cancer Res., February 15, 2004; 10(4): 1375 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Okochi, K. Hibi, M. Sakai, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao Methylation-Mediated Silencing of SOCS-1 Gene in Hepatocellular Carcinoma Derived from Cirrhosis Clin. Cancer Res., November 1, 2003; 9(14): 5295 - 5298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hibi, S.-i. Fujitake, T. Takase, Y. Kodera, K. Ito, S. Akiyama, M. Shirane, and A. Nakao Identification of S100A2 as a Target of the {Delta}Np63 Oncogenic Pathway Clin. Cancer Res., September 15, 2003; 9(11): 4282 - 4285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lottin, E. Adriaenssens, T. Dupressoir, N. Berteaux, C. Montpellier, J. Coll, T. Dugimont, and J. J. Curgy Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells Carcinogenesis, November 1, 2002; 23(11): 1885 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Okochi, K. Hibi, T. Uemura, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao Detection of Mitochondrial DNA Alterations in the Serum of Hepatocellular Carcinoma Patients Clin. Cancer Res., September 1, 2002; 8(9): 2875 - 2878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamazaki, K. Hibi, T. Takase, E. Tezel, H. Nakayama, Y. Kasai, K. Ito, S. Akiyama, T. Nagasaka, and A. Nakao PGP9.5 as a Marker for Invasive Colorectal Cancer Clin. Cancer Res., January 1, 2002; 8(1): 192 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Ravenel, K. W. Broman, E. J. Perlman, E. L. Niemitz, T. M. Jayawardena, D. W. Bell, D. A. Haber, H. Uejima, and A. P. Feinberg Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor J Natl Cancer Inst, November 21, 2001; 93(22): 1698 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hibi, H. Nakayama, M. Taguchi, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao AIS Overexpression in Advanced Esophageal Cancer Clin. Cancer Res., March 1, 2001; 7(3): 469 - 472. [Abstract] [Full Text]
|
|
|
|
|
|
S. Lai, H. Goepfert, A. M. Gillenwater, M. A. Luna, and A. K. El-Naggar Loss of Imprinting and Genetic Alterations of the Cyclin-dependent Kinase Inhibitor p57KIP2 Gene in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., August 1, 2000; 6(8): 3172 - 3176. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Hibi, B. Trink, M. Patturajan, W. H. Westra, O. L. Caballero, D. E. Hill, E. A. Ratovitski, J. Jen, and D. Sidransky AIS is an oncogene amplified in squamous cell carcinoma PNAS, May 9, 2000; 97(10): 5462 - 5467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Falls, D. J. Pulford, A. A. Wylie, and R. L. Jirtle Genomic Imprinting: Implications for Human Disease Am. J. Pathol., March 1, 1999; 154(3): 635 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Lepretre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.-J. Curgy H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression Am. J. Pathol., November 1, 1998; 153(5): 1597 - 1607. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
